Cryosite (ASX:CTE) Total Liabilities: A$22.94 Mil (As of Dec. 2025)


ASX:CTE Cryosite Ltd ASX:CTE
51 GF Score
Price A$1.25
GF Value A$0.94
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cryosite Total Liabilities?

Cryosite ASX:CTE 51 Total Liabilities is A$22.94 Mil as of Dec. 2025. GuruFocus rates ASX:CTE with a GF Score™ of 51/100 and a GF Value™ of A$0.94 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Cryosite's Total Liabilities for the quarter that ended in Dec. 2025 was A$22.94 Mil.

Cryosite's quarterly Total Liabilities declined from Dec. 2024 (A$17.77 Mil) to Jun. 2025 (A$17.08 Mil) but then increased from Jun. 2025 (A$17.08 Mil) to Dec. 2025 (A$22.94 Mil).

Cryosite's annual Total Liabilities declined from Jun. 2023 (A$19.87 Mil) to Jun. 2024 (A$18.26 Mil) and declined from Jun. 2024 (A$18.26 Mil) to Jun. 2025 (A$17.08 Mil).

Cryosite Total Liabilities Historical Data

* Premium members only.

The historical data trend for Cryosite's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryosite Total Liabilities Chart

Cryosite Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.62 19.64 19.87 18.26 17.08

Cryosite Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.28 18.26 17.77 17.08 22.94
ASX:CTE
51GF Score
Cryosite Ltd ASX:CTE
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryosite Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cryosite's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.532+(2.068+9.937
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.096+0.442)
=17.08

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=19.464-2.389
=17.08

Cryosite's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11.221+(1.959+9.314
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0.442)
=22.94

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=26.545-3.609
=22.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of A$22.94 Mil mean?
Cryosite (ASX:CTE) has a Total Liabilities of A$22.94 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cryosite and its competitors.
Is Cryosite's Total Liabilities too high?
Cryosite's current Total Liabilities is A$22.94 Mil. Overall, Cryosite has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cryosite's Total Liabilities compare to TMO and DHR?
Cryosite's Total Liabilities of A$22.94 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cryosite and its competitors. Cryosite's current Total Liabilities is A$22.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryosite stock overvalued right now?
Based on GuruFocus' analysis, Cryosite (ASX:CTE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.94, compared to a current price of A$1.25 — trading 33% above its estimated fair value. The current Total Liabilities is A$22.94 Mil. Cryosite's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Cryosite (ASX:CTE), the current Total Liabilities is A$22.94 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryosite (ASX:CTE) Overvalued in 2026?

Based on GuruFocus' analysis, Cryosite stock appears to be overvalued. The current stock price of A$1.25 is trading 33% above its estimated GF Value™ of A$0.94. GuruFocus considers Cryosite to be Significantly Overvalued.

Key valuation signals for ASX:CTE:

  • Total Liabilities: A$22.94 Mil
  • GF Value™: A$0.94 vs. price of A$1.25 (33% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the ASX:CTE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cryosite Business Description

Address 13a Ferndell Street, South Granville, Sydney, NSW, AUS, 2142
Cryosite Ltd provides an integrated clinical trial logistics service, biological storage and sample management service, including the storage of cord blood stem cells for private use. It supports a diverse portfolio of materials, including Good Manufacturing Practice (GMP) clinical trial products, Australian Register of Therapeutic Goods (ARTG) approved medicines, biologics, Research and Development materials, and medical devices, among others. The group's operating segments are: Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord blood. The majority of its revenue is generated from the Ambient, cold, and frozen segment, which provides storage and distribution of small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions.
51GF Score

Get the complete analysis for ASX:CTE

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.25
Price
A$0.94
GF Value